At a glance
ClinicalIndex Comparison RecordN/ACompleted· 565 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
In Brief
An observational study for Epilepsy and Pregnancy. Completed, enrolled 565 participants across 20 sites.
Detailed Summary
Epilepsy is one of the most common neurological disorders affecting women of childbearing age. Poor pregnancy outcomes are increased in these women and their children. The proposed studies will increase our knowledge on multiple levels to improve care and reduce adverse outcomes in these mothers and children. An overall goal of this study is to establish the relationship between antiepileptic drug exposure and outcomes in the mother and child as well as describe and explain the variability in antiepileptic drug exposure and response.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 2012
Enrollment StartJan 2013
Primary CompletionDec 2022
TodayJul 2026
First PostedNov 21, 2012
Enrollment StartJan 1, 2013
Primary CompletionDec 12, 2022
TodayJul 2, 2026
Enrollment to primary: 9.9 yearsPosted 13.6 years ago